1. Home
  2. Prostate cancer
  Subject:

Prostate cancer   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Prostatectomy Radiation therapy Prostate Gleason grading system Prostate-specific antigen Gene Metastasis Protein Androgen Magnetic resonance imaging Prostate cancer Lymph node Chemotherapy Breast cancer Carcinoma Biopsy International Prostate Symptom Score DNA Polymerase chain reaction Messenger RNA Acid Western blot Apoptosis Testosterone Syndrome Estrogen receptor Androgen receptor CT scan Nuclear magnetic resonance Medical ultrasound
RELATED SUBJECTS:
The publications listed also have these subjects
Prostate  8 times
Magnetic resonance imaging  7 times
Radiation therapy  6 times
Metastasis  6 times
Protein  5 times
Prostatectomy  5 times
Apoptosis  5 times
Lymph node  4 times
Gleason grading system  4 times
Biopsy  4 times
Adjuvant therapy  4 times
PubMed  3 times
Prostate-specific antigen  3 times
Progression-free survival  3 times
Multivariate analysis  3 times
High-intensity focused ultrasound  3 times
Gene  3 times
Estrogen receptor  3 times
Enzyme inhibitor  3 times
Disease  3 times
Clinical trial  3 times
Urinary incontinence  2 times
The Cancer Genome Atlas  2 times
Syndrome  2 times
Seminal vesicle  2 times
Positron  2 times
Pharmacokinetics  2 times
Iodine-125  2 times
Interquartile range  2 times
IC50  2 times
Histopathology  2 times
Flow cytometry  2 times
Embase  2 times
DNA  2 times
Confidence interval  2 times
Cochrane Library  2 times
Chemotherapy  2 times
Breast cancer  2 times
Bladder cancer  2 times
Biomarker  2 times
Bioavailability  2 times
Androgen  2 times
Algorithm  2 times
Adenocarcinoma  2 times
Acid  2 times
Zeta potential  1 time
Western blot  1 time
Vitamin D  1 time
Urology  1 time
Urinary tract infection  1 time
Urinary retention  1 time
Urinary bladder  1 time
Univariate analysis  1 time
Ultrasound  1 time
Transcription factor  1 time
Trace element  1 time
Time point  1 time
Surgical margin  1 time
Staphylococcus epidermidis  1 time
Socioeconomic status  1 time
Small interfering RNA  1 time
Single-photon emission computed tomography  1 time
Shared decision-making in medicine  1 time
Scopus  1 time
Scintillator  1 time
Repeated measures design  1 time
Red blood cell  1 time
Receiver operating characteristic  1 time
Radioactive tracer  1 time
Positron emission tomography–magnetic resonance imaging  1 time
Positron emission tomography  1 time
Polyphenol  1 time
Phosphoinositide 3-kinase  1 time
Pancreatic cancer  1 time
Palliative care  1 time
Oxime  1 time
Ovarian cancer  1 time
Nuclear medicine  1 time
Notch signaling pathway  1 time
Nomogram  1 time
Nitric oxide  1 time
Neutron activation analysis  1 time
Mycelium  1 time
Myc  1 time
Microarray  1 time
Metformin  1 time
Messenger RNA  1 time
Malondialdehyde  1 time
Magnesium  1 time
MEDLINE  1 time
MCF-7  1 time
Lysine  1 time
Lymphadenectomy  1 time
Lung cancer  1 time
Los Angeles  1 time
Logistic regression  1 time
Lipid peroxidation  1 time
International Prostate Symptom Score  1 time
Interleukin 6  1 time
Immunofluorescence  1 time
Immunocytochemistry  1 time
ImageJ  1 time
Hyperphosphatemia  1 time
Hypercholesterolemia  1 time
Hydrogen peroxide  1 time
Hormone  1 time
Honey  1 time
Hemostasis  1 time
Hemolysis  1 time
HeLa  1 time
HMS Urge  1 time
Growth factor  1 time
Gram-positive bacteria  1 time
Godfrey Hounsfield  1 time
Genome  1 time
Gelatin  1 time
Gallium  1 time
G1 phase  1 time
Fungus  1 time
Fluorine-18  1 time
Fasting  1 time
Fallopian tube  1 time
External beam radiotherapy  1 time
Erectile dysfunction  1 time
Epithelial–mesenchymal transition  1 time
Epigenetics  1 time
Enterococcus faecalis  1 time
Embolization  1 time
Dutch language  1 time
Driving under the influence  1 time
Dosimetry  1 time
DNA methylation  1 time
DAPI  1 time
Cytochrome P450  1 time
Cyclin  1 time
Curcumin  1 time
Cryoablation  1 time
Confocal microscopy  1 time
Cone beam computed tomography  1 time
Colorectal cancer  1 time
Cofactor (biochemistry)  1 time
Cluster analysis  1 time
ClinicalTrials.gov  1 time
Clinical pathway  1 time
Chromatin  1 time
Cholesterol  1 time
Chi-squared test  1 time
ChIP-sequencing  1 time
Cervix  1 time
Cell cycle  1 time
Catenin  1 time
Cascading Style Sheets  1 time
Carboxylic acid  1 time
Carbonyl group  1 time
California  1 time
Cadherin  1 time
CT scan  1 time
CINAHL  1 time
Bone marrow  1 time
Blood plasma  1 time
Benzyl group  1 time
Benign prostatic hyperplasia  1 time
Bcl-2  1 time
Backscatter  1 time
Bacillus  1 time
BT Group  1 time
Australia  1 time
Aureus  1 time
Antioxidant  1 time
Antigen  1 time
Antibody  1 time
Angiogenesis  1 time
Androgen receptor  1 time
Anastomosis  1 time
Analysis of variance  1 time
Alanine transaminase  1 time
Alanine  1 time
Adipose tissue  1 time
Adenosine diphosphate ribose  1 time
Acetone  1 time
Ablation  1 time
AEC Regent III RT  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence

2. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis

3. New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?

4. Inhibition of cancer cell invasiveness by synthetic peptides GEGEEGEE and DFGEEAEE

5. Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation

6. Effects of resistance exercise in prostate cancer patients: a meta-analysis

7. Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer

8. Whole pelvis radiotherapy for pathological node-positive prostate cancer

9. Pros-IT CNR: an Italian prostate cancer monitoring project

10. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection

11. Intervention for patient reported urinary symptoms in prostate cancer survivors: Systematic review

12. Bioactivity of arid region honey: an in vitro study

13. Talking About Your Prostate: Perspectives from Providers and Community Members

14. The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

15. Chemopreventive effect of saponin isolated from Gymnema sylevestre on prostate cancer through in silico and in vivo analysis

16. Outcomes across the return-to-work process in PC survivors attending a rehabilitation measure—results from a prospective study

17. Antibacterial and anticancer activities of acetone extracts from in vitro cultured lichen-forming fungi

18. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients

19. Clinical validation of real-time tissue change monitoring during prostate tissue ablation with high intensity focused ultrasound

20. Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates

21. Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime

22. Cancer metastasis: issues and challenges

23. Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells

24. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile

25. [68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients

26. How do treatment aims in the last phase of life relate to hospitalizations and hospital mortality? A mortality follow-back study of Dutch patients with five types of cancer

27. Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)

28. Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life

29. Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?

30. Therapeutic effects of curcumin nanoemulsions on prostate cancer

31. Voiding Dysfunction, Incontinence, and Erectile Dysfunction Following High-Intensity Focus Ultrasound and Focal Cryotherapy in Treatment of Prostate Cancer

32. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells

33. Prostate Knowledge, Attitudes and Beliefs in Black College Men: A Qualitative Study

34. Metformin and Prostate Cancer: a New Role for an Old Drug

35. Prostate Cancer in the Elderly Male: Diagnostic and Management Considerations

36. Niraparib: First Global Approval

37. Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies

38. Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer

39. The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells

40. Follow-up care after treatment for prostate cancer: protocol for an evaluation of a nurse-led supported self-management and remote surveillance programme

41. Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial

42. Stereotactic ablative radiotherapy with targeted MRI-defined gross tumor dose escalation for prostate cancer: dosimetric feasibility and interfraction robustness

43. Advances in Imaging in Prostate and Bladder Cancer

44. MR/US Fusion Technology: What Makes It Tick?

45. Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug – Croton membranaceus Müll.Arg

46. A novel TOF-PET MRI detector for diagnosis and follow up of the prostate cancer

47. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT

48. When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study

49. Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions

50. Multimodal imaging in focal therapy planning and assessment in primary prostate cancer


Questions?

Drop us a message.